|
PANK4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.539800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.167400E-01 |
| Normal-vs-Stage2 |
6.354400E-01 |
| Normal-vs-Stage3 |
6.376800E-03 |
| Normal-vs-Stage4 |
1.288620E-01 |
| Stage1-vs-Stage2 |
7.320600E-01 |
| Stage1-vs-Stage3 |
1.495810E-02 |
| Stage1-vs-Stage4 |
3.790200E-01 |
| Stage2-vs-Stage3 |
7.827600E-02 |
| Stage2-vs-Stage4 |
3.772800E-01 |
| Stage3-vs-Stage4 |
4.050200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.737800E-02 |
| Normal-vs-AfricanAmerican |
3.284000E-01 |
| Normal-vs-Asian |
7.498600E-01 |
| Caucasian-vs-AfricanAmerican |
8.903400E-01 |
| Caucasian-vs-Asian |
2.279200E-01 |
| AfricanAmerican-vs-Asian |
5.372800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.811400E-01 |
| Normal-vs-Female |
4.637900E-02 |
| Male-vs-Female |
2.620600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.092800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.305900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.832400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.838620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.285400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.466200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.331200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.759800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.710200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.709200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.896900E-03 |
| Classical-VS-Follicular |
1.256620E-01 |
| Classical-VS-Other |
8.714000E-01 |
| Classical-VS-Normal |
3.906800E-01 |
| Tall-VS-Follicular |
1.316750E-01 |
| Tall-VS-Other |
2.260200E-01 |
| Tall-VS-Normal |
1.344880E-03 |
| Follicular-VS-Other |
7.582400E-01 |
| Follicular-VS-Normal |
5.961700E-02 |
| Other-VS-Normal |
5.717000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.396200E-02 |
| Normal-vs-N1 |
1.081590E-02 |
| N0-vs-N1 |
2.038200E-01 |
|
|
